195 related articles for article (PubMed ID: 30593759)
41. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW
Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621
[TBL] [Abstract][Full Text] [Related]
42. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
43. Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia.
Walker JS; Hing ZA; Harrington B; Baumhardt J; Ozer HG; Lehman A; Giacopelli B; Beaver L; Williams K; Skinner JN; Cempre CB; Sun Q; Shacham S; Stromberg BR; Summers MK; Abruzzo LV; Rassenti L; Kipps TJ; Parikh S; Kay NE; Rogers KA; Woyach JA; Coppola V; Chook YM; Oakes C; Byrd JC; Lapalombella R
J Hematol Oncol; 2021 Jan; 14(1):17. PubMed ID: 33451349
[TBL] [Abstract][Full Text] [Related]
44. A novel diagnostic biosensor for distinguishing immunoglobulin mutated and unmutated types of chronic lymphocytic leukemia.
Ensafi AA; Amini M; Rezaei B; Talebi M
Biosens Bioelectron; 2016 Mar; 77():409-15. PubMed ID: 26436328
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
[TBL] [Abstract][Full Text] [Related]
46. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
47. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
[TBL] [Abstract][Full Text] [Related]
48. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state.
Herling M; Patel KA; Khalili J; Schlette E; Kobayashi R; Medeiros LJ; Jones D
Leukemia; 2006 Feb; 20(2):280-5. PubMed ID: 16341048
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
50. New prognostic markers in chronic lymphocytic leukemia.
Moreno C; Montserrat E
Blood Rev; 2008 Jul; 22(4):211-9. PubMed ID: 18448218
[TBL] [Abstract][Full Text] [Related]
51. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
[TBL] [Abstract][Full Text] [Related]
52. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
54. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
[TBL] [Abstract][Full Text] [Related]
55. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.
Shahjahani M; Mohammadiasl J; Noroozi F; Seghatoleslami M; Shahrabi S; Saba F; Saki N
Cell Oncol (Dordr); 2015 Apr; 38(2):93-109. PubMed ID: 25563586
[TBL] [Abstract][Full Text] [Related]
56. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
[TBL] [Abstract][Full Text] [Related]
57. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.
Buccheri V; Barreto WG; Fogliatto LM; Capra M; Marchiani M; Rocha V
Ann Hematol; 2018 Dec; 97(12):2269-2278. PubMed ID: 30315344
[TBL] [Abstract][Full Text] [Related]
58. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
[TBL] [Abstract][Full Text] [Related]
59. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
60. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
